Has Stephanie Horrocks received payments from drug or device companies?

Yes. Drug and device makers reported $12,143 in general payments to Stephanie Horrocks across 513 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Stephanie Horrocks did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Stephanie Horrocks come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Stephanie Horrocks

Nurse Practitioner · Baltimore, MDNPI 1821557414

Payments from drug & device makers

$12,143in general payments, 2019–2025

Across 513 payments — averaging $23.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Johnson & Johnson$1K
Novartis$904
Pfizer$735
AstraZeneca$640
Incyte Corporation$614
Seagen Inc.$573
plus $8K from 54 others

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Johnson & Johnson(2 entities)	33	$1,101
Novartis	50	$904
Pfizer	32	$735
AstraZeneca(2 entities)	27	$640
Incyte Corporation	27	$614
Seagen Inc.	19	$573
AbbVie	25	$558
E.r. Squibb & Sons, L.L.C.	28	$515
Takeda Pharmaceuticals U.S.A., Inc.	19	$454
Regeneron Healthcare Solutions, Inc.	14	$344
Lilly USA, LLC	12	$324
Pharmaessentia USA Corporation	11	$311
Bristol Myers Squibb	18	$306
Pharmacyclics LLC, An Abbvie Company	12	$292
Beigene USA, Inc.	12	$283
Daiichi Sankyo Inc.	9	$265
AVEO Pharmaceuticals, Inc.	4	$259
Amgen	11	$258
Merck	14	$256
EMD Serono, Inc.	9	$226
GSK	13	$221
Taiho Oncology, Inc.	8	$218
Genentech USA, Inc.	8	$200
Agios Pharmaceuticals, Inc.	7	$194
Sanofi	7	$182
Gilead(2 entities)	8	$162
Eisai Inc.	6	$141
Astellas Pharma US Inc	7	$135
Boehringer Ingelheim	5	$124
Mirati Therapeutics, Inc.	5	$115
Exelixis Inc.	5	$113
Jazz Pharmaceuticals Inc.	3	$92
EUSA Pharma (US) LLC	4	$89
Beone Medicines USA, Inc.	4	$85
Kyowa Kirin, Inc.	3	$72
Array Biopharma Inc	3	$70
Syndax Pharmaceuticals, Inc.	2	$54
Legend Biotech USA Inc.	2	$52
Bayer	2	$51
Puma Biotechnology, Inc.	2	$39
Accord Healthcare, Inc.	2	$39
Deciphera Pharmaceuticals Inc.	2	$39
Genmab U.S., Inc.	1	$35
Novocure Inc.	1	$33
Sobi, Inc	1	$31
Stemline Therapeutics Inc.	1	$30
Adaptive Biotechnologies Corporation	1	$29
Immunogen, Inc.	1	$26
Sumitomo Pharma America, Inc.	1	$25
Ipsen Biopharmaceuticals, Inc	1	$24
Acrotech Biopharma Inc.	1	$24
Spectrum Pharmaceuticals Inc.	1	$23
Caris MPI, Inc.	1	$22
Helsinn Therapeutics (U.S.), Inc.	1	$20
Alnylam Pharmaceuticals Inc.	1	$19
Blueprint Medicines Corporation	1	$19
Invivyd Inc	1	$18
Coherus Oncology, Inc.	1	$15
Recordati_rare_diseases_inc.	1	$15
Tolmar, Inc.	1	$15

How this compares

$12,143 in reported general payments places this provider in the 95th percentile of 1,562 nurse practitioner providers in Maryland.

See all nurse practitioner providers in Maryland →

Medicare billing

Part B allowed, 2024

$573,005

Medicare patients

278

Services billed

43,657

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other nurse practitioner in Baltimore

Sherilyn BrinkleyBaltimore$100K
Michelle TurnerBaltimore$94K
Zeev NemirovskyBaltimore$19K
Sandra WoodringBaltimore$12K
Inna BardoffBaltimore$11K
Linda RyanBaltimore$10K
Laura HostovichBaltimore$8K
Denese GaughanBaltimore$7K
Arita McCoyBaltimore$7K
Elisheva BadianBaltimore$7K

See the full list for Maryland →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →